KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scansource (SCSC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Scansource (SCSC) over the last 17 years, with Q4 2025 value amounting to $663.6 million.

  • Scansource's Cost of Revenue rose 276.07% to $663.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.6 billion, marking a year-over-year decrease of 70.22%. This contributed to the annual value of $2.6 billion for FY2025, which is 799.06% down from last year.
  • As of Q4 2025, Scansource's Cost of Revenue stood at $663.6 million, which was up 276.07% from $632.2 million recorded in Q3 2025.
  • Scansource's 5-year Cost of Revenue high stood at $895.9 million for Q4 2022, and its period low was $604.6 million during Q1 2025.
  • Its 5-year average for Cost of Revenue is $731.5 million, with a median of $747.7 million in 2021.
  • In the last 5 years, Scansource's Cost of Revenue skyrocketed by 3461.03% in 2021 and then plummeted by 2262.29% in 2024.
  • Quarter analysis of 5 years shows Scansource's Cost of Revenue stood at $756.4 million in 2021, then rose by 18.44% to $895.9 million in 2022, then dropped by 12.49% to $784.0 million in 2023, then decreased by 17.64% to $645.8 million in 2024, then rose by 2.76% to $663.6 million in 2025.
  • Its Cost of Revenue stands at $663.6 million for Q4 2025, versus $632.2 million for Q3 2025 and $707.8 million for Q2 2025.